Discovery of JANUVIA ™ (Sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes Posted on October 30, 2006 Ann Weber Seminar Series: Contemporary Biochemistry Host: Monday, October 30, 2006 – 3:30 PM